Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-009506·KING LUTHER CAPITAL MANAGEMENT CORP
Schedule 13G ownership disclosure
SCPHARMACEUTICALS INC
Common Stock · CUSIP: 810648105
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Luther King Capital Management Corporation
Shares: 2,857,910 · Class: 5.7%
- J. Luther King, Jr.
Shares: 2,980,410 · Class: 6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-009506
- Form type
- SCHEDULE 13G/A
- Filer
- KING LUTHER CAPITAL MANAGEMENT CORP
- CIK
- CIK 310051
- Filed
- Jan 28, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership